This genotype-dependent dysregulation likely arises from altered VDR-mediated transcriptional control of IL17A and IL23A loci, implicating VDR polymorphisms as modifiers of IL-23/Th17 axis hyperactivity in psoriasis pathogenesis. The gene discussed is IL23A; the disease is psoriasis.